Skip to main content
. 2021 Jul 3;69:103457. doi: 10.1016/j.ebiom.2021.103457

Fig.7.

Fig.7

Dasatinib enhances antitumor effects of Vorinostat in preclinical SCLC mouse models. A, Volumes of GLC15 xenografts treated with vehicle or the indicated drugs. **p < 0.01, ***p < 0.001 by two-way ANOVA. B, Tumor weights at the end of the treatment. Representative images of tumour size in each group were shown to the right. *p < 0.05 by one-way ANOVA.